Schedule 13G ownership disclosure
CHINA SXT PHARMACEUTICALS IN
Ordinary shares, $0.51 per Ordinary Share and associated Warrants · CUSIP: G2161P157
Event date: 2025-07-29
- Filing-level shares
- 10,392,160.00
- Percent of class
- 8.95%
- TAN SOO SENG
Shares: 10,392,160.00 · Class: 8.95%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-072838
- Form type
- SCHEDULE 13G
- Filer
- China SXT Pharmaceuticals, Inc.
- CIK
- CIK 1723980
- Filed
- Aug 07, 2025
- Reporting period
- Jul 29, 2025
- Description
- Schedule 13G beneficial ownership